Hjem › Mesoteliom › Texas › Houston
Mesoteliom kliniske forsøg i Houston, TX
15 studier for Mesoteliom søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
SW-682 in Advanced Solid Tumors
RekruttererFase 1
- U.T. MD Anderson Cancer Center, Houston
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
- Baylor St Lukes, Houston
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
- MD Anderson, Houston
- NEXT Oncology Houston, Houston
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- The University of Texas MD Anderson Cancer Center, Houston
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
RekruttererFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RekruttererFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RekruttererFase 1
- MDACC, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
RekruttererFase 1
- MD Anderson Cancer Center, Houston
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
A Study of VET3-TGI in Patients With Solid Tumors
RekruttererFase 1
- University of Texas MD Anderson Cancer Center, Houston
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekruttererFase 1/2
- The University of Texas MD Anderson Cancer Center (site 127), Houston
A Study of NX-1607 in Adults With Advanced Malignancies
RekruttererFase 1
- MD Anderson Cancer Center, Houston
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
RekruttererFase 1
- MD Anderson Cancer Center, Houston
Mesoteliom forsøg i andre byer
- New York City, NY10 studier
- Washington, DC9 studier
- Chicago, IL9 studier
- Nashville, TN8 studier
- Boston, MA8 studier
- Arlington, VA6 studier
- Philadelphia, PA6 studier
- Pittsburgh, PA6 studier
- Seattle, WA6 studier
- Los Angeles, CA6 studier
- Rochester, MN5 studier
- Columbus, OH5 studier
Andre studier i Houston
- Ikke-småcellet lungecancer145 studier
- Brystkræft126 studier
- Kræft (alle typer)121 studier
- Metastatisk cancer104 studier
- Colorektal kræft102 studier
- Ægstockræft89 studier
- Akut myeloid leukæmi85 studier
- Lungecancer78 studier
- Prostatakræft76 studier
- Livmoderslimhindekræft68 studier
- Bugspytkirtelkræft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.